Skip to main content

Research Repository

Advanced Search

Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk

Halkes, P.H.A.; Gray, Laura J.; Bath, Philip M.W.; Diener, Hans-Christoph; Guiraud-Chaumeil, B.

Authors

P.H.A. Halkes

Laura J. Gray

Philip M.W. Bath

Hans-Christoph Diener

B. Guiraud-Chaumeil



Abstract

Objectives: Our aim was to study the effect of combination therapy with aspirin and dipyridamole (A+D) over aspirin alone (ASA) in secondary prevention after transient
ischemic attack or minor stroke of presumed arterial origin and to perform subgroup analyses to identify patients that might benefit most from secondary prevention with A+D.
Data sources: The previously published meta-analysis of individual patient data was updated with data from ESPRIT (N=2,739); trials without data on the comparison of A+D versus ASA were excluded.
Review methods: A meta-analysis was performed using Cox regression, including several subgroup analyses and following baseline risk stratification.
Results: A total of 7,612 patients (5 trials) were included in the analyses, 3,800 allocated to A+D and 3,812 to ASA alone. The trial-adjusted hazard ratio for the composite event of vascular death, non-fatal myocardial infarction and non-fatal stroke was 0.82 (95% confidence interval 0.72-0.92). Hazard ratios did not differ in subgroup analyses based on age, sex, qualifying event, hypertension, diabetes, previous stroke, ischemic heart disease,
aspirin dose, type of vessel disease and dipyridamole formulation, nor across baseline risk strata as assessed with two different risk scores. A+D were also more effective than ASA alone in preventing recurrent stroke, HR 0.78 (95% CI 0.68 – 0.90).
Conclusion: The combination of aspirin and dipyridamole is more effective than aspirin alone in patients with TIA or ischemic stroke of presumed arterial origin in the secondary
prevention of stroke and other vascular events. This superiority was found in all subgroups and was independent of baseline risk. ---------------------------7dc3521430776
Content-Disposition: form-data; name="c14_creators_1_name_family"

Halkes

Citation

Halkes, P., Gray, L. J., Bath, P. M., Diener, H., & Guiraud-Chaumeil, B. (2008). Dipyridamole plus aspirin versus aspirin alone in the secondary prevention after TIA or stroke: a meta-analysis by risk. Journal of Neurology, Neurosurgery and Psychiatry, 79(11), doi:10.1136/jnnp.2008.143875

Journal Article Type Article
Publication Date Nov 1, 2008
Deposit Date Jun 8, 2012
Publicly Available Date Jun 8, 2012
Journal Journal of Neurology, Neurosurgery and Psychiatry
Print ISSN 0022-3050
Electronic ISSN 0022-3050
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Volume 79
Issue 11
DOI https://doi.org/10.1136/jnnp.2008.143875
Public URL http://eprints.nottingham.ac.uk/id/eprint/969
Publisher URL http://jnnp.bmj.com/content/79/11/1218.full
Copyright Statement Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf

Files


jnnp.2008.143875v2_dipyridamole_oct_08.pdf (152 Kb)
PDF

Copyright Statement
Copyright information regarding this work can be found at the following address: http://eprints.nottingham.ac.uk/end_user_agreement.pdf





You might also like



Downloadable Citations